DE60133734D1 - Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen - Google Patents
Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungenInfo
- Publication number
- DE60133734D1 DE60133734D1 DE60133734T DE60133734T DE60133734D1 DE 60133734 D1 DE60133734 D1 DE 60133734D1 DE 60133734 T DE60133734 T DE 60133734T DE 60133734 T DE60133734 T DE 60133734T DE 60133734 D1 DE60133734 D1 DE 60133734D1
- Authority
- DE
- Germany
- Prior art keywords
- bordetella
- pertactin
- pertussis
- repeated regions
- parapertussis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108010021711 pertactin Proteins 0.000 title abstract 8
- 241000588780 Bordetella parapertussis Species 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 201000005702 Pertussis Diseases 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 102000054765 polymorphisms of proteins Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 241000588779 Bordetella bronchiseptica Species 0.000 abstract 2
- 241000588832 Bordetella pertussis Species 0.000 abstract 2
- 208000018150 Bordetella infection Diseases 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000002480 immunoprotective effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20696900P | 2000-05-25 | 2000-05-25 | |
| US206969P | 2000-05-25 | ||
| PCT/EP2001/006457 WO2001090143A2 (en) | 2000-05-25 | 2001-05-23 | Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60133734D1 true DE60133734D1 (de) | 2008-06-05 |
| DE60133734T2 DE60133734T2 (de) | 2009-05-14 |
Family
ID=22768696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60133734T Expired - Lifetime DE60133734T2 (de) | 2000-05-25 | 2001-05-23 | Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7070779B2 (de) |
| EP (1) | EP1284993B1 (de) |
| JP (1) | JP2003533990A (de) |
| AT (1) | ATE393166T1 (de) |
| AU (1) | AU2001267527A1 (de) |
| CY (1) | CY1110430T1 (de) |
| DE (1) | DE60133734T2 (de) |
| DK (1) | DK1284993T3 (de) |
| ES (1) | ES2303833T3 (de) |
| PT (1) | PT1284993E (de) |
| WO (1) | WO2001090143A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2646776B1 (fr) * | 1989-05-12 | 1994-06-03 | Pasteur Institut | Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella |
| DE60133734T2 (de) | 2000-05-25 | 2009-05-14 | Institut Pasteur | Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen |
| WO2008146830A1 (ja) | 2007-05-28 | 2008-12-04 | The Kitasato Institute | パラ百日咳菌全菌体ワクチン組成物 |
| CU23679A1 (es) * | 2007-10-30 | 2011-07-11 | Ct Ingenieria Genetica Biotech | Variantes de pertactinas para uso vacunal |
| EP2430040A1 (de) * | 2009-05-11 | 2012-03-21 | Novartis AG | Antigenaufreinigungsverfahren für pertactinantigen |
| US8261986B2 (en) * | 2009-10-21 | 2012-09-11 | Kevin Kwong-Tai Chung | System and method for decoding an optically readable markable sheet and markable sheet therefor |
| EP2670431A1 (de) * | 2011-02-04 | 2013-12-11 | Zoetis LLC | Zusammensetzungen für komplexe atemwegserkrankung bei hunden |
| JP5833145B2 (ja) * | 2011-02-04 | 2015-12-16 | ゾエティス・エルエルシー | 免疫原性ｂｏｒｄｅｔｅｌｌａｂｒｏｎｃｈｉｓｅｐｔｉｃａ組成物 |
| CN109879942A (zh) * | 2019-03-01 | 2019-06-14 | 浙江省农业科学院 | 一种兔波氏杆菌外膜蛋白及其制备方法和用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9007416D0 (en) * | 1990-04-02 | 1990-05-30 | Wellcome Found | Expression of heterologous protein in yeast |
| GB9027901D0 (en) * | 1990-12-21 | 1991-02-13 | Wellcome Found | Acellular vaccine |
| FR2728170A1 (fr) * | 1994-12-15 | 1996-06-21 | Pasteur Institut | Vaccin de type acellulaire anti-bordetella |
| DE60133734T2 (de) | 2000-05-25 | 2009-05-14 | Institut Pasteur | Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen |
-
2001
- 2001-05-23 DE DE60133734T patent/DE60133734T2/de not_active Expired - Lifetime
- 2001-05-23 WO PCT/EP2001/006457 patent/WO2001090143A2/en active IP Right Grant
- 2001-05-23 PT PT01945261T patent/PT1284993E/pt unknown
- 2001-05-23 EP EP01945261A patent/EP1284993B1/de not_active Expired - Lifetime
- 2001-05-23 DK DK01945261T patent/DK1284993T3/da active
- 2001-05-23 ES ES01945261T patent/ES2303833T3/es not_active Expired - Lifetime
- 2001-05-23 AT AT01945261T patent/ATE393166T1/de active
- 2001-05-23 JP JP2001586330A patent/JP2003533990A/ja active Pending
- 2001-05-23 AU AU2001267527A patent/AU2001267527A1/en not_active Abandoned
- 2001-09-10 US US09/855,754 patent/US7070779B2/en not_active Expired - Fee Related
-
2002
- 2002-11-25 US US10/302,896 patent/US6964767B2/en not_active Expired - Lifetime
-
2005
- 2005-03-25 US US11/088,785 patent/US7314910B2/en not_active Expired - Fee Related
-
2008
- 2008-07-08 CY CY20081100716T patent/CY1110430T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001090143A3 (en) | 2002-09-26 |
| EP1284993A2 (de) | 2003-02-26 |
| ES2303833T3 (es) | 2008-09-01 |
| US7070779B2 (en) | 2006-07-04 |
| ATE393166T1 (de) | 2008-05-15 |
| US7314910B2 (en) | 2008-01-01 |
| AU2001267527A1 (en) | 2001-12-03 |
| PT1284993E (pt) | 2008-06-11 |
| DK1284993T3 (da) | 2008-07-28 |
| US20030180307A1 (en) | 2003-09-25 |
| JP2003533990A (ja) | 2003-11-18 |
| US20060008474A1 (en) | 2006-01-12 |
| WO2001090143A2 (en) | 2001-11-29 |
| EP1284993B1 (de) | 2008-04-23 |
| US20040166116A9 (en) | 2004-08-26 |
| DE60133734T2 (de) | 2009-05-14 |
| US20020192237A1 (en) | 2002-12-19 |
| US6964767B2 (en) | 2005-11-15 |
| CY1110430T1 (el) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199901305T2 (xx) | Calpain-�nleyicileri olarak ketonbenzamidler | |
| DK1660528T3 (da) | Mutein af tåre-lipocalin | |
| BR0108711A (pt) | Expressão heteróloga de proteìnas de neisseria | |
| ATE128974T1 (de) | Neue kondensierte heterocyclische verbindungen und ihre verwendung für heilmittel. | |
| DK0696297T3 (da) | Pyridobisimidazolbaseret stiv stavpolymer | |
| RS51157B (sr) | Baff receptor (bcma), imunoregulatorni agens | |
| CY1110430T1 (el) | Πολυπεπτιδια περιεχοντα πολυμορφισμους των επαναλαμβανομενων περιοχων της περτακτινης σε bordetella pertussis, bordetella paraperussis kai bordetella bronchiseptica. χρηση αυτων σε διαγνωστικες και ανοσογονες συνθεσεις | |
| ATE526994T1 (de) | Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten | |
| BR0315644A (pt) | Piperazinil e diazapanil benzamidas e benzotioamidas | |
| HRP20050270A2 (en) | Substituierte heterocyclylpyrimidine | |
| ATE381575T1 (de) | Veränderte borrelia burgdorferi ospa | |
| DE69018926D1 (de) | Vakzine gegen Bordetella. | |
| DE60140972D1 (de) | Antigene aus Cryptosporidium parvum, Antikörper dagegen und diagnostische und therapeutische Zusammensetzungen | |
| AP2049A (en) | Medicament containing activated antithrombin III | |
| ATE420951T1 (de) | Schützende epitope von adenylate-zyklase- hämolysin(ac-hly) und ihre verwendung zur behandlung oder verhütung von bordetella- infektionen | |
| Chapman et al. | Silence at Ramscliffe | |
| MXPA02012015A (es) | Ligandos de receptores para integrinas. | |
| BR0316544A (pt) | Compostos calcilìticos | |
| ES2185605T3 (es) | 2,3-dihidro-1h-5,9-dioxaciclohepta (f) inden-7-onas 1,2-sustituidas y benzo (b) (1,4)dioxepin-3 onas 7-sustituidas. | |
| DE60312953D1 (de) | Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol | |
| SE0201207D0 (sv) | A process for production of a regioselective membrane | |
| DE69834504D1 (de) | Nicht-toxische immun-stimulierende enterotoxin-zusammensetzungen | |
| TR200000154T2 (tr) | 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler. | |
| IL159493A0 (en) | Pharmaceutical formulation containing an ltb4 antagonist | |
| FR2838962B1 (fr) | Composition cosmetique comprenant un extrait de lentilles d'eau riche en apiose, procedes de traitement et utilisations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |